台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    94.3
  • 漲跌
    ▲1.1
  • 漲幅
    +1.18%
  • 成交量
    337
  • 產業
    上櫃 生技醫療類股▲0.31%
  • 303人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智擎 (4162)籌碼相關-凱基-南京 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-南京 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2018/07/1311151.275149.30151.0061,3150.46%
2018/07/101130.5000.00132.0011,1660.09%
2018/07/094134.0000.00132.0041,1720.34%
2018/07/0400.002133.50134.00-21,157-0.17%
2018/06/042151.001144.00150.0019380.11%
2018/06/018137.067140.21139.0018770.11%
2018/05/2900.001127.50131.50-1830-0.12%
2018/04/2300.006151.42149.00-6843-0.71%
2018/04/191150.504151.63149.50-3887-0.34%
2018/04/1300.003151.83151.00-3873-0.34%
2018/04/021149.001150.00148.5008280.00%
2018/03/231140.0000.00140.5017650.13%
2018/03/2200.003146.83144.00-3754-0.40%
2018/03/211143.0000.00142.0017320.14%
2018/03/1600.001140.50144.50-1731-0.14%
2018/03/0900.001134.50133.50-1783-0.13%
2018/03/013129.5000.00129.0037970.38%
2018/02/261130.5000.00128.5018070.12%
2018/02/2200.003133.00132.00-3799-0.38%
2018/02/126124.1700.00122.5067960.75%
2018/02/091123.0000.00123.5017880.13%
2018/01/031155.001153.00151.5008950.00%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章